echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Mov Disord: The later the menopause, the lower the prevalence of Parkinson's disease

    Mov Disord: The later the menopause, the lower the prevalence of Parkinson's disease

    • Last Update: 2021-09-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    As we all know, the incidence of Parkinson's disease (PD) in men is higher than in women
    .


    For a long time, the neuroprotective effects of sex hormones have been considered a potential cause of this difference



    In observational studies, the relationship between the life-long level of female sex hormones and PD was extensively explored through alternative measures of self-reported menarche age and menopausal age
    .


    Unfortunately, the research results, including meta-analysis, are inconsistent



    Therefore, as the time of menopause increases, women are likely to find it increasingly difficult to accurately recall the time of their last menstrual period: the inconsistency in menopausal age reported in repeated interviews also proves this
    .


    Misreports and missing values ​​of age at menopause or menarche are unlikely to be random events, and are more likely in case-control studies related to aging, because this information is often collected many years after the transition to menopause occurs



    One way to solve these technical problems is through the use of Mendelian randomization (MR) analysis
    .


    MR analysis is based on the association between genetic variants and exposure, as well as the association between genetic variants and disease states, so that genetic variants serve as instrumental variables



    GWAS

    After the MR analysis, a replication and meta-analysis was performed using aggregate statistics from a large PD alliance
    .


    Based on the hypothesis that female hormones may protect dopamine neurons, they assessed whether older menopause or younger menarche are related to a reduction in the risk of women's PD


    Based on the hypothesis that female hormones may protect dopamine neurons, they assessed whether older menopause or younger menarche are related to a reduction in the risk of women's PD


    In their study, for every one year of menopausal age, women’s risk of PD decreases (odds ratio [OR], 0.


    84; 95% confidence interval [CI], 0.
    73-0.


    Using PD Consortium’s summary statistics for replication, the estimated OR was 0.
    94 (95% CI, 0.
    90-0.
    99; P = 0.
    01), while the calculated meta-analysis OR was 0.
    93 (95% CI, 0.
    89-0.
    98; P = 0.
    003)
    .

    There is no indication that there is an association between age at menarche and PD (OR, 0.
    75; 95% CI, 0.
    44-1.
    29; P = 0.
    29)
    .

    There is no indication that there is an association between age at menarche and PD (OR, 0.
    75; 95% CI, 0.
    44-1.
    29; P = 0.
    29)
    .


    The important significance of this study lies in the discovery that the later age of women's menopause is related to the reduced risk of PD, supporting the hypothesis that sex hormones or other factors related to late menopause may have a neuroprotective effect on PD
    .

    Women’s later menopause age is associated with a lower risk of PD.

     

    Original source:

    Kusters CDJ, Paul KC, Duarte Folle A, et al.
    Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
    Mov Disord.
    Published online August 23, 2021:mds.
    28760.
    doi:10.
    1002/mds.
    28760

    Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.